The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
A prognostic index in primary breast cancer
Open accessAbstract
From a multiple-regression analysis of prognostic factors and survival in a series of 387 patients with primary breast cancer, a prognostic index has been constructed, based on lymph-node stage, tumour size and pathological grade. This index is more discriminating than lymph-node stage alone, and enables a larger group of patients to be identified with a very poor prognosis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Regression Models and Life-Tables
Cox, D. R. (1972) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1972.tb00899.x · Cited by 39,793
Bloom, H. J. G., & Richardson, W. W. (1957) · British Journal of Cancer · doi:10.1038/bjc.1957.43 · Cited by 2,925
Mm, B., Opler, S. R., & Speer, F. D. (1955) · PubMed · Cited by 160
Maynard, P. V., Davies, C., Blamey, R. W., Elston, C. W., Johnson, J. H., & Griffiths, K. (1978) · British Journal of Cancer · doi:10.1038/bjc.1978.282 · Cited by 136
Self-citationRELATIONSHIP OF ŒSTROGEN-RECEPTOR STATUS TO SURVIVAL IN BREAST CANCER
Bishop, H., Elston, C. W., Blamey, R. W., Haybittle, J. L., Nicholson, R. I., & Griffiths, K. (1979) · The Lancet · doi:10.1016/s0140-6736(79)90295-2 · Cited by 117
Self-citationThe Relative Significance of Prognostic Factors in Breast Carcinoma
Alderson, M., Hamlin, I., & Staunton, M. D. (1971) · British Journal of Cancer · doi:10.1038/bjc.1971.80 · Cited by 96
Prognostic Factors in Mammary Carcinoma
Wallgren, A., Silfverswärd, C., & EKLUND, G. A. (1976) · Acta Radiologica Therapy Physics Biology · doi:10.3109/02841867609132703 · Cited by 58
The use of prognostic factors in predicting survival for breast cancer patients
Myers, M. H., Axtell, L. M., & Zelen, M. (1966) · Journal of Chronic Diseases · doi:10.1016/0021-9681(66)90008-7 · Cited by 35
Cited by
ELSTON, C. W., & ELLIS, I. O. (1991) · Histopathology · doi:10.1111/j.1365-2559.1991.tb00229.x · Cited by 6,175
Self-citationMoons, K. G. M., Altman, D. G., Reitsma, J. B., Ioannidis, J. P. A., Macaskill, P., Steyerberg, E. W., Vickers, A. J., Ransohoff, D. F., & Collins, G. S. (2015) · Annals of Internal Medicine · doi:10.7326/m14-0698 · Cited by 5,147
Collins, G. S., Reitsma, J. B., Altman, D. G., & Moons, K. G. M. (2015) · BMJ · doi:10.1136/bmj.g7594 · Cited by 4,388
Collins, G. S., Reitsma, J. B., Altman, D. G., & Moons, K. G. M. (2015) · British Journal of Cancer · doi:10.1038/bjc.2014.639 · Cited by 3,293
Collins, G. S., Reitsma, J. B., Altman, D. G., & Moons, K. G. M. (2015) · Annals of Internal Medicine · doi:10.7326/m14-0697 · Cited by 3,267
Calculating the sample size required for developing a clinical prediction model
Riley, R. D., Ensor, J., Snell, K. I. E., Harrell, F. E., Martin, G. P., Reitsma, J. B., Moons, K. G. M., Collins, G., & van Smeden, M. (2020) · BMJ · doi:10.1136/bmj.m441 · Cited by 2,917
Collins, G. S., Reitsma, J. B., Altman, D. G., & Moons, K. (2015) · BMC Medicine · doi:10.1186/s12916-014-0241-z · Cited by 1,927
“These and other reviews provide a clear picture that, across different disease areas and different journals, there is a generally poor level of reporting of prediction model studies [6,2-27,29].”
Pathological prognostic factors in breast cancer
Elston, C. (1999) · Critical Reviews in Oncology/Hematology · doi:10.1016/s1040-8428(99)00034-7 · Cited by 1,735
Self-citationPrognosis Research Strategy (PROGRESS) 3: Prognostic Model Research
Steyerberg, E. W., Moons, K. G. M., van der Windt, D. A., Hayden, J. A., Perel, P., Schroter, S., Riley, R. D., Hemingway, H., Altman, D. G., & for the PROGRESS Group (2013) · PLoS Medicine · doi:10.1371/journal.pmed.1001381 · Cited by 1,508
Riley, R. D., Snell, K. I., Ensor, J., Burke, D. L., Harrell Jr, F. E., Moons, K. G., & Collins, G. S. (2019) · Statistics in Medicine · doi:10.1002/sim.7992 · Cited by 1,409
The Nottingham prognostic index in primary breast cancer
Galea, M. H., Blamey, R. W., Elston, C. E., & Ellis, I. O. (1992) · Breast Cancer Research and Treatment · doi:10.1007/bf01840834 · Cited by 1,070
Self-citationAssessment and comparison of prognostic classification schemes for survival data
Graf, E., Schmoor, C., Sauerbrei, W., & Schumacher, M. (1999) · Statistics in Medicine · doi:10.1002/(sici)1097-0258(19990915/30)18:17/18<2529::aid-sim274>3.0.co;2-5 · Cited by 975
Richard, J., Sainsbury, C., Needham, G., Farndon, J., Malcolm, A., & Harris, A. (1987) · The Lancet · doi:10.1016/s0140-6736(87)90593-9 · Cited by 892
Collins, G. S., Reitsma, J. B., Altman, D. G., & Moons, K. G. M. (2015) · British Journal of Surgery · doi:10.1002/bjs.9736 · Cited by 889
Collins, G. S., Reitsma, J. B., Altman, D. G., & Moons, K. G. M. (2015) · Circulation · doi:10.1161/circulationaha.114.014508 · Cited by 793
“Well-known prediction models include the Framingham Risk Score (7), Ottawa Ankle Rules (8), EuroScore (9), Nottingham Prognostic Index (10), and the Simplified Acute Physiology Score (11).”
Genetic Reclassification of Histologic Grade Delineates New Clinical Subtypes of Breast Cancer
Ivshina, A. V., George, J., Senko, O., Mow, B., Putti, T. C., Smeds, J., Lindahl, T., Pawitan, Y., Hall, P., Nordgren, H., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-4414 · Cited by 752
UPDATE OF THE SWEDISH TWO-COUNTY PROGRAM OF MAMMOGRAPHIC SCREENING FOR BREAST CANCER
Tabàr, L., Fagerberg, G., Duffy, S. W., Day, N. E., Gad, A., & Gröntoft, O. (1992) · Radiologic Clinics of North America · doi:10.1016/s0033-8389(22)02494-0 · Cited by 731
Expression of luminal and basal cytokeratins in human breast carcinoma
Abd El‐Rehim, D. M., Pinder, S. E., Paish, C. E., Bell, J., Blamey, R., Robertson, J. F., Nicholson, R. I., & Ellis, I. O. (2004) · The Journal of Pathology · doi:10.1002/path.1559 · Cited by 594
Self-citationRiley, R. D., Ensor, J., Snell, K. I. E., Debray, T. P. A., Altman, D. G., Moons, K. G. M., & Collins, G. S. (2016) · BMJ · doi:10.1136/bmj.i3140 · Cited by 585
Repression of E-cadherin by the polycomb group protein EZH2 in cancer
Cao, Q., Yu, J., Dhanasekaran, S. M., Kim, J. H., Mani, R.-S., Tomlins, S. A., Mehra, R., Laxman, B., Cao, X., Yu, J., et al. (2008) · Oncogene · doi:10.1038/onc.2008.333 · Cited by 583
The Relation between Survival and Age at Diagnosis in Breast Cancer
Adami, H.-O., Malker, B., Holmberg, L., Persson, I., & Stone, B. (1986) · New England Journal of Medicine · doi:10.1056/nejm198608283150906 · Cited by 549
EPIDERMAL-GROWTH-FACTOR RECEPTORS AND OESTROGEN RECEPTORS IN HUMAN BREAST CANCER
Sainsbury, J. R. C., Sherbet, G. V., Farndon, J. R., & Harris, A. L. (1985) · The Lancet · doi:10.1016/s0140-6736(85)91385-6 · Cited by 492
Collins, G. S., Reitsma, J. B., Altman, D. G., & Moons, K. G. M. (2015) · European Urology · doi:10.1016/j.eururo.2014.11.025 · Cited by 439
Stuart-Harris, R., Caldas, C., Pinder, S. E., & Pharoah, P. (2008) · The Breast · doi:10.1016/j.breast.2008.02.002 · Cited by 431
Wishart, G. C., Azzato, E. M., Greenberg, D. C., Rashbass, J., Kearins, O., Lawrence, G., Caldas, C., & Pharoah, P. D. (2010) · Breast Cancer Research · doi:10.1186/bcr2464 · Cited by 418
E-cadherin expression in primary carcinomas of the breast and its distant metastases
Kowalski, P. J., Rubin, M. A., & Kleer, C. G. (2003) · Breast Cancer Research · doi:10.1186/bcr651 · Cited by 414
Elston, C. W., & Ellis, I. O. (2002) · Histopathology · doi:10.1046/j.1365-2559.2002.14691.x · Cited by 380
Self-citationLipocalin 2 promotes breast cancer progression
Yang, J., Bielenberg, D. R., Rodig, S. J., Doiron, R., Clifton, M. C., Kung, A. L., Strong, R. K., Zurakowski, D., & Moses, M. A. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0810617106 · Cited by 356
Collins, G. S., Reitsma, J. B., Altman, D. G., & Moons, K. G. M. (2015) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2014.11.010 · Cited by 324
Dawson, S.-J., Makretsov, N., Blows, F. M., Driver, K. E., Provenzano, E., Le Quesne, J., Baglietto, L., Severi, G., Giles, G. G., McLean, C. A., et al. (2010) · British Journal of Cancer · doi:10.1038/sj.bjc.6605736 · Cited by 317
Confirmation of a prognostic index in primary breast cancer
Todd, J., Dowle, C., Williams, M., Elston, C., Ellis, I., Hinton, C., Blamey, R., & Haybittle, J. (1987) · British Journal of Cancer · doi:10.1038/bjc.1987.230 · Cited by 308
Self-citationFOXP3 Expression and Overall Survival in Breast Cancer
Merlo, A., Casalini, P., Carcangiu, M. L., Malventano, C., Triulzi, T., Mènard, S., Tagliabue, E., & Balsari, A. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.17.9036 · Cited by 301
PINDER, S. E., ELLIS, I. O., GALEA, M., O'ROUKE, S., BLAMEY, R. W., & ELSTON, C. W. (1994) · Histopathology · doi:10.1111/j.1365-2559.1994.tb01269.x · Cited by 287
Self-citationMethodological challenges in the evaluation of prognostic factors in breast cancer.
Altman, D. G., & Lyman, G. H. (1998) · Breast Cancer Research and Treatment · doi:10.1023/a:1006193704132 · Cited by 271
Contesso, G., Mouriesse, H., Friedman, S., Genin, J., Sarrazin, D., & Rouesse, J. (1987) · Journal of Clinical Oncology · doi:10.1200/jco.1987.5.9.1378 · Cited by 261
Ki67 immunostaining in primary breast cancer: pathological and clinical associations
Bouzubar, N., Walker, K., Griffiths, K., Ellis, I., Elston, C., Robertson, J., Blamey, R., & Nicholson, R. (1989) · British Journal of Cancer · doi:10.1038/bjc.1989.200 · Cited by 259
Self-citationHenson, D. E., Ries, L., Freedman, L. S., & Carriaga, M. (1991) · Cancer · doi:10.1002/1097-0142(19911115)68:10<2142::aid-cncr2820681010>3.0.co;2-d · Cited by 253
Improved breast cancer histological grading using deep learning
Wang, Y., Acs, B., Robertson, S., Liu, B., Solorzano, L., Wählby, C., Hartman, J., & Rantalainen, M. (2022) · Annals of Oncology · doi:10.1016/j.annonc.2021.09.007 · Cited by 211
Stability of clinical prediction models developed using statistical or machine learning methods
Riley, R. D., & Collins, G. S. (2023) · Biometrical Journal · doi:10.1002/bimj.202200302 · Cited by 211
Characterization of RhoC Expression in Benign and Malignant Breast Disease
Kleer, C. G., van Golen, K. L., Zhang, Y., Wu, Z.-F., Rubin, M. A., & Merajver, S. D. (2002) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64877-8 · Cited by 157
Clift, A. K., Dodwell, D., Lord, S., Petrou, S., Brady, M., Collins, G. S., & Hippisley-Cox, J. (2023) · BMJ · doi:10.1136/bmj-2022-073800 · Cited by 97
Levy, T. J., Coppa, K., Cang, J., Barnaby, D. P., Paradis, M. D., Cohen, S. L., Makhnevich, A., van Klaveren, D., Kent, D. M., Davidson, K. W., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-34646-2 · Cited by 14
Metadata
- Authors
- Haybittle, J. L., Blamey, R. W., Elston, C. W., Johnson, J., Doyle, P. J., Campbell, F. C., Nicholson, R. I., & Griffiths, K.
- Venue
- British Journal of Cancer
- Published
- 1982-03
- Volume
- 45
- Issue
- 3
- Pages
- 361-366
- ISSN
- 0007-0920 (ISSN-L)
- 1532-1827
- OpenAlex
- W1996624321
- Cited by
- 699
- References
- 8
- FWCI
- 9.17
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.